Skip to main content
bioRxiv

Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling

Publication ,  Preprint
Chen, G; Luo, H; Luo, X; Singh, S; Ramirez, J; James, M; Mathew, J; Berger, M; Eroglu, C; Ji, R-R
2022

Duke Scholars

DOI

Publication Date

2022
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, G., Luo, H., Luo, X., Singh, S., Ramirez, J., James, M., … Ji, R.-R. (2022). Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling. bioRxiv. https://doi.org/10.1101/2022.03.28.486142
Chen, Gang, Hao Luo, Xin Luo, Sandeep Singh, Juan Ramirez, Michael James, Joseph Mathew, Miles Berger, Cagla Eroglu, and Ru-Rong Ji. “Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling.” BioRxiv, 2022. https://doi.org/10.1101/2022.03.28.486142.
Chen G, Luo H, Luo X, Singh S, Ramirez J, James M, et al. Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling. bioRxiv. 2022.
Chen, Gang, et al. “Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling.” BioRxiv, 2022. Epmc, doi:10.1101/2022.03.28.486142.
Chen G, Luo H, Luo X, Singh S, Ramirez J, James M, Mathew J, Berger M, Eroglu C, Ji R-R. Sparcl1/Hevin drives inflammatory and neuropathic pain through astrocyte and NMDA receptor signaling. bioRxiv. 2022.

DOI

Publication Date

2022